Unlock instant, AI-driven research and patent intelligence for your innovation.

Medical composition

A composition and coating technology, applied in the direction of drug combination, drug delivery, non-active ingredients of polymer compounds, etc., can solve problems affecting patient compliance and poor palatability

Inactive Publication Date: 2007-01-31
GLAXO GRP LTD
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] Although the lipid coating masks to some extent the bitter taste of cefuroxime axetil when administered orally, the bitter taste of cefuroxime axetil is so strong that these suspensions and compositions still have a bitter taste, and when administered to children There are obvious problems
Additionally, the suspensions may have a "gritty" feel in the mouth, making them less palatable than other antibiotic suspensions
These factors may affect patient compliance because, especially in young children, unpalatable antibiotics tend to be discontinued once the patient improves, rather than continuing the course until the scheduled period

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Cefuroxime axetil suspension 125mg / 5ml

[0050] Component 5mL dose %w / w

[0051] Cefuroxime axetil 0.150g 3.55

[0052] Stearic acid 0.852g 20.19

[0053] Povidone 0.013g 0.31

[0054] Tutti Frutti flavoring 0.100g 2.37

[0055] Sucrose 3.062g 72.56

[0056] Acesulfame Potassium 0.021g 0.50

[0057] Aspartame 0.021g 0.50

[0058] Xanthan gum 0.001g 0.02

[0059] Drinking water to 5mL

Embodiment 2

[0061] Cefuroxime axetil suspension 125mg / 5ml

[0062] Component 5mL dose %w / w

[0063] Cefuroxime axetil 0.150g 3.55

[0064] Stearic acid 0.852g 20.19

[0065] Povidone 0.013g 0.31

[0066] Tutti Frutti flavoring 0.100g 2.37

[0067] Sucrose 3.062g 72.56

[0068] Sodium saccharin 0.021g 0.50

[0069] Aspartame 0.021g 0.50

[0070] Xanthan gum 0.001g 0.02

[0071] Drinking water to 5mL

Embodiment 3

[0073] Cefuroxime axetil suspension 125mg / 5ml

[0074] Component 5mL dose %w / w

[0075] Cefuroxime axetil 0.150g 3.55

[0076] Stearic acid 0.852g 20.19

[0077] Povidone 0.013g 0.31

[0078] Tutti Frutti flavoring 0.100g 2.37

[0079] Sucrose 3.062g 72.56

[0080] Sodium saccharin 0.021g 0.50

[0081] Acesulfame Potassium 0.021g 0.50

[0082] Xanthan gum 0.001g 0.02

[0083] Drinking water to 5mL

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A composition comprising cefuroxime axetil in particulate form, the particles being coated with integral coatings of a lipid or mixture of lipids which are insoluble in water in which the composition further comprises a sweetener system and a texture modifier which serves to mask the bitter taste of cefuroxime axetil upon oral administration is disclosed.

Description

technical field [0001] The present invention relates to compositions, in particular to pharmaceutical compositions containing 1-acetoxyethyl ester of cefuroxime, whose approved name is cefuroxime axetil. Background technique [0002] Cefuroxime as disclosed in British Patent Specification 1453049 is a valuable broad-spectrum antibiotic characterized by high activity against a wide range of Gram-positive and Gram-negative Enhanced by the very high stability of β-lactamases produced by a wide range of Gram-negative microorganisms. Cefuroxime and its salts are primarily used as injectable antibiotics because of their poor absorption from the gastrointestinal tract. [0003] Esterification of the carboxyl group of cefuroxime to 1-acetoxyethyl ester to give cefuroxime axetil improves the efficiency of oral administration as disclosed in British Patent Specification 1571683. The presence of the 1-acetoxyethyl ester group results in substantial absorption of the compound from the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/546A61P31/04A61K9/10A61K9/00A61K9/14A61K9/16A61K9/30A61K9/50A61K31/545A61K47/20A61K47/22A61K47/26A61K47/32A61K47/36A61K47/38A61K47/42A61P31/00
CPCA61K31/545A61K9/1617A61K31/546A61K9/0095A61P31/00A61P31/04A61K9/16A61K47/183A61K47/22
Inventor 马蒂尔德·I·费尔南德斯埃米莉奥·S·加里茨
Owner GLAXO GRP LTD